Skip to content

McKesson MCK Restructuring Reserve

Restructuring Reserve at other companies

Cardinal Health logo
Cardinal HealthCAH
Viatris logo
ViatrisVTRS
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX

Segments

By segment

See full
North American Pharmaceutical$18M+63.6%
Medical-Surgical Solutions$10M-88.9%
Prescription Technology Solutions$3M+200%
Oncology & Multispecialty$0

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.9%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$87.88B+25.7%
Enterprise value$86.18B+19.6%
P/E18.5×-2.8×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:RestructuringReserve.

The official record: McKesson’s 10-Q, filed February 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's restructuring reserve.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's restructuring reserve?
McKesson (MCK) reported restructuring reserve of $35M in Q4 2025.
How has McKesson's restructuring reserve changed year-over-year?
McKesson's restructuring reserve decreased by 77.7% year-over-year, from $157M to $35M.
What is the long-term trend for McKesson's restructuring reserve?
Over 4 years (2021 to 2025), McKesson's restructuring reserve has grown at a -4.4% compound annual growth rate (CAGR), from $151M to $126M.